IBM, Averion and Winchester Business Systems have been doing collaborative seminars linking the technologies of all three companies. As Winchester noted in a release about a recent seminar in the Boston area: “The current systems used by most organizations—individual spreadsheets and disconnected databases—cannot support the increased volume and complexity of these trials. In fact, they can significantly slow down the time to close-out and increase the risk of FDA rejection due to incomplete or noncompliant information.”